Takai Noriyuki, Kira Naoko, Ishii Terukazu, Yoshida Toshie, Nishida Masakazu, Nishida Yoshihiro, Nasu Kaei, Narahara Hisashi
Department of Obstetrics and Gynecology, Oita University Faculty of Medicine, Oita, Japan.
Asian Pac J Cancer Prev. 2012;13(1):399-402. doi: 10.7314/apjcp.2012.13.1.399.
Bufalin is a traditional oriental medicines which induces apoptosis in some lines of human tumor cells. It constitutes the major digoxin-like immunoreactive component of Chan Su, obtained from the skin and parotid venom glands of toads. Bufalin is cardioactive C-24 steroids that exhibits a variety of biological activities, such as cardiotonic, anaesthetic, blood pressure stimulatory, respiratory and antineoplastic effects. In terms of its anti-tumor activity, bufalin has been demonstrated to inhibit the growth of tumors, such as endometrial and ovarian cancers. This commentary introduces biologic and therapeutic effects of bufalin in treating some cancers. The compound is able to mediate inhibition of cell growth, cell cycle arrest, apoptosis, and expression of genes related to the malignant phenotype in human cancer cells.
蟾毒灵是一种能诱导某些人类肿瘤细胞系凋亡的传统东方药物。它是蟾酥中主要的类地高辛免疫反应性成分,蟾酥取自蟾蜍的皮肤和腮腺毒液腺。蟾毒灵是具有心脏活性的C - 24甾体,具有多种生物学活性,如强心、麻醉、刺激血压、呼吸及抗肿瘤作用。就其抗肿瘤活性而言,蟾毒灵已被证明能抑制肿瘤生长,如子宫内膜癌和卵巢癌。本述评介绍了蟾毒灵在治疗某些癌症方面的生物学和治疗作用。该化合物能够介导对人类癌细胞的细胞生长抑制、细胞周期阻滞、凋亡以及与恶性表型相关基因的表达。